BioCentury
ARTICLE | Clinical News

ABT-894 meets ADHD endpoint

June 21, 2008 12:11 AM UTC

NeuroSearch (CSE:NEUR) said ABT-894 met the primary endpoint of a significant improvement vs. placebo in Conner's Adult ADHD Rating Scale (CAARS-Inv) Total Score in a U.S. Phase II trial to treat ADHD...